Tin tức & Cập nhật
Xem bài viết Ung thư
Xem
Chỉ hiển thị Multimedia

Response to first-line treatment tied to longer survival in HER2-positive breast cancer
30 Mar 2024
Patients with de novo human epidermal growth receptor 2 (HER2)-positive metastatic breast cancer (MBC) who show radiographic response to first-line HER2-directed therapy are more likely to achieve long-term survival, suggests a recent study.
30 Mar 2024

SBRT as effective as Y90 for HCC, but cheaper
29 Mar 2024
Use of either stereotactic body radiotherapy (SBRT) or yttrium-90 (Y90) is effective in the management of hepatocellular carcinoma (HCC), resulting in similar overall and progression-free survival, reports a study. However, Y90 is more expensive than SBRT.
29 Mar 2024

How common is lymphedema among breast cancer patients in Singapore?
26 Mar 2024
bởiStephen Padilla
The rates of breast cancer-related lymphedema (BCRL) in Singapore are similar to those across the globe, reports a Singapore study. In addition, the findings also stress the comparable profiles of patients who are vulnerable to the disease.
26 Mar 2024





